Tag: therapeutics

March 30, 2019

New to the Investing News Network

Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...
March 13, 2019

NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN”

NervGen Pharma Corp. ("NervGen" or the "Company"), a regenerative medicine company dedicated to creating innovative solutions for the treatment of...
December 31, 2018

New to the Investing News Network

Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping...
November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
November 13, 2018

CRISPR Trials to Watch in 2018

CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
November 12, 2018

Why Invest in Nanotech Stocks?

Nanotech benefits areas as diverse as cancer therapies and solar energy solutions. Here's why you should consider nanotech stocks.
September 29, 2018

Cannabis Weekly Round-Up: Ontario Shares Retail Restrictions

The Investing News Network rounds up some of the biggest company and market news in the cannabis market for the...